期刊文献+

腹腔镜治疗老年胃十二指肠穿孔的临床疗效及安全性观察 被引量:6

Clinical efficacy and safety of laparoscopy in the treatment of elderly patients with gastric and duodenal perforation
下载PDF
导出
摘要 目的探讨腹腔镜治疗老年胃十二指肠穿孔的临床疗效及安全性。方法根据手术治疗方式不同将92例老年胃十二指肠穿孔患者分为实验组(52例)和对照组(40例),分别行腹腔镜穿孔修补术和开腹穿孔修补术,比较两组临床疗效及安全性。结果实验组患者平均手术时间、术后排气时间、胃肠功能恢复时间和住院时间均短于对照组,术中出血量少于对照组,术后并发症发生率(5.8%)低于对照组(20.0%),差异有统计学意义(P<0.05);两组术后疗效比较差异无统计学意义(P>0.05)。结论腹腔镜手术治疗老年胃十二指肠穿孔微创优势明显,可促进患者术后尽快恢复,且安全性较高,推荐作为临床治疗该类病症的首选术式。 Objective To analyze the clinical efficacy and safety of laparoscopy in the treatment of elderly patients with gastric and duodenal perforation. Methods A total of 92 elderly patients with gastric and duodenal perforation were divided into experimental group (n=52) who accepted the laparoscopy, and control group (n=40) who accepted the open surgery. The clinical efficacy and safety between the two groups were compared after surgery. Results The surgery duration, the postoperative exhaust time, the time of functional recovery of gastrointestinal tract and the hospitalization time in experimental group were shorter than those in control group, The amount of bleeding during surgery in the, experimental group was less than that in the control group. The incidence rate of complication in experimental group(5.8%) was significant lower than that in control group (20.0%) (P〈0.05). There was no significant difference between the two group on the efficacy after operation(P〉0.05). Conclusion The laparoscopy in the treatment of elderly patients with gastric and duodenal perforation has more advantages. The restore time after the laparoscopy is shorter than the traditional procedure. It should be recommended as the first choice in the treatment of gastric and duodenal perforation.
作者 阎海
出处 《中国现代医生》 2016年第25期36-38,共3页 China Modern Doctor
关键词 胃十二指肠穿孔 老年患者 腹腔镜手术 微创 Gastric and duodenal perforation Elderly patient Laparoscopy Minimally invasive
  • 相关文献

参考文献17

二级参考文献140

  • 1吴在德 吴肇汉.外科学[M].北京:人民卫生出版社,2003,8.900.
  • 2Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neu- roendocrine turnours. Lancet Oncol 2008; 9: 61-72.
  • 3Kloppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroentero- pancreatic neuroendocrine tumors. Virchows Arch 2007; 451(S1 1): S9-27.
  • 4Caldarella A, Crocetti E, Paci E. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol Oncol Res 2011 : 17: 759-63.
  • 5Kuiper P, Verspaget HW, Overbeek LI, Biemond I, Lamers CB. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Neth JMed 2011; 69: 14-20.
  • 6Levinsky NG. Fluid and electrolytes.In: Thom GW, Ad- ams RD, Braunwald E, Editors. Harrison's Principles of Internal Medicine, 8th edition. New York: McGrawHill, 1977: 364-75.
  • 7Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-59.
  • 8Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": epidemi- ology of and prognostic factors for neuroendocrine tu- mors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-72.
  • 9Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113: 2655-64.
  • 10Turaga KK, Kvols LK. Recent progress in the under- standing, diagnosis, and treatment of gastroenteropan- creatic neuroendocrine tumors. CA Cancer J Clin 2011; 61: 113-32.

共引文献128

同被引文献18

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部